$MSA (MSA Safety Incorporated)

$MSA {{ '2016-08-30T18:52:41+0000' | timeago}} • Announcement

Safety products company $MSA said its BoD has appointed Anne Herman as Chief Customer Officer and Vice President of Global Quality. Ms. Herman has held a variety of positions within $MSA's R&D, Quality, Standards Compliance, and Operations groups.

$UTX {{ '2017-07-25T12:34:46+0000' | timeago}} • Announcement

$UTX said new equipment orders at Otis were flat for 2Q17 versus the prior year. Despite Carrier's plan to relocate fan coils manufacturing to Mexico and layoffs, orders at UTC Climate, Controls & Security increased by 11% organically. Commercial aftermarket sales were up 4% at Pratt & Whitney and were up 7% at UTC Aerospace Systems.

$BIIB {{ '2017-07-25T12:18:23+0000' | timeago}} • Announcement

$BIIB Biogen Inc. Earnings AlphaGraphic: Q2 2017 Highlights

$UTX {{ '2017-07-25T12:16:57+0000' | timeago}} • Announcement

$UTX lifted its FY17 sales outlook to $58.5-59.5Bil from $57.5-59Bil, while narrowing its adjusted EPS guidance to $6.45-6.60 from $6.30-6.60. This is based on its strong year-to-date performance and outlook for the remainder of 2017. Following this, $UTX stock, which touched new 52-week of $124.79 recently, is trading higher in premarket session.

$UTX {{ '2017-07-25T12:12:05+0000' | timeago}} • Announcement

Following the uplift of dividend by 6.1% last month, $UTX's 2Q17 earnings came in-line with its expectations, on strategic priorities execution, including growth of its business through investments, aerospace backlog delivery, and cost reduction goals achievement. This was made despite maintaining a disciplined approach to capital allocation.

$UTX {{ '2017-07-25T12:07:01+0000' | timeago}} • Announcement

Diversified conglomerate $UTX reported a rise in 2Q17 earnings driven by lower income tax expenses, despite a rise in costs and expenses. Income from continuing operations rose 1% to $1.43Bil and EPS increased 5% to $1.80. Sales grew 3% to $15.3Bil, including a 3% organic growth. Adjusted EPS from continuing operations rose 2% to $1.85.

$UTX {{ '2017-07-25T11:34:00+0000' | timeago}} • Infographic

$UTX United Technologies Earnings AlphaGraphic: Q2 2017 Highlights.

$MSI {{ '2017-07-24T18:07:53+0000' | timeago}} • Announcement

$MSI has filed fresh patent infringement complaints in the Regional Court of Mannheim in Germany against Hytera Communications Corporation Limited of Shenzhen, China and Hytera Mobilfunk GmbH of Bad Munder, Germany (collectively, “Hytera”). Similar complaints were filed against Hytera in the Regional Court of Düsseldorf on April 18, 2017.

$BMY {{ '2017-07-24T16:32:02+0000' | timeago}} • Announcement

$BMY said the U.S. Food and Drug Administration (FDA) has expanded the indication for Yervoy (ipilimumab) injection for intravenous use to now include the treatment of unresectable or metastatic melanoma in pediatric patients 12 years of age and older.

$ABBV {{ '2017-07-21T16:09:32+0000' | timeago}} • Announcement

$ABBV received positive opinion from the European Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency for Humira (adalimumab) for the treatment of chronic non-infectious anterior uveitis in pediatric patients. Uveitis is an inflammation of the uvea, which includes the iris, choroid, and the ciliary body in eye.

$HUBB {{ '2017-07-21T16:05:05+0000' | timeago}} • Announcement

$HUBB's BoD declared a regular quarterly dividend of $0.70 per share on its common stock. The dividend will be paid on Sept. 15, 2017 to shareholders of record on Aug. 31, 2017.

$ENDP {{ '2017-07-21T14:56:21+0000' | timeago}} • Announcement

$ENDP said it will be ceasing operations and closing its manufacturing and distribution facilities in Huntsville, Alabama. The closure is expected to take place over the next 12 to 18 months. These restructuring actions are expected to reduce $ENDP's workforce by about 875 positions and to result in pre-tax restructuring charges of about $325MM.

$ABT {{ '2017-07-20T19:55:45+0000' | timeago}} • Webcast

For 3Q17, $ABT expects adjusted EPS of $0.64-0.66, with operational sales growth expected in the mid-single digits. At current exchange rates, the company expects operational sales growth to have a negative YoY impact of around 0.5%.

$ABT {{ '2017-07-20T19:45:56+0000' | timeago}} • Webcast

$ABT said that on a comparable operational basis, 3Q17 Established Pharmaceuticals sales growth is expected in the high double-digit, while in Nutrition, sales growth is expected in low single-digit. In Diagnostics, $ABT expects sales to increase mid-to-high single digits and in Medical Devices, sales is expected to increase double-digits.

$ABT {{ '2017-07-20T17:49:19+0000' | timeago}} • Announcement

$ABT raised its full year profit forecast backed by the intention of closing the Alere acquisition in 2017. The company raised its FY17 adjusted earnings from continuing operations guidance by $0.03 to a range of $2.43-2.53 per share. Reported EPS forecast was also raised from the range of $0.92-1.02 to $1.03-1.13, reflecting double-digit growth.

$ABT {{ '2017-07-20T17:36:53+0000' | timeago}} • Announcement

Declining operating earnings and rising costs and expenses hit $ABT 2Q17 earnings as much as 54%. Earnings plunged to $283MM or $0.15 from $615MM or $0.40 per share a year earlier. Sales, however, surged 24.4% on St. Jude Medical acquisition. On an adjusted basis, $ABT reported EPS above its previous guidance range at $0.62 per share.

$INCY {{ '2017-07-20T13:24:37+0000' | timeago}} • Announcement

$INCY said first patient has been treated in Phase 3 trial of itacitinib for the first-line treatment of patients with acute graft-versus-host disease (GVHD). GVHD is a condition that might occur after an allogeneic transplant, whereby the donated bone marrow or peripheral blood stem cells view the recipient’s body as foreign and attack the body.

$ABT {{ '2017-07-20T12:52:57+0000' | timeago}} • Infographic

$ABT Abbott Laboratories Earnings AlphaGraphic: Q2 2017 Highlights

$RPM {{ '2017-07-19T13:03:55+0000' | timeago}} • Announcement

$RPM appointed Julie Lagacy to its BoD, effective immediately, and has nominated Robert Livingston as a director candidate for election to the board at its annual stockholders' meeting on Oct. 5, 2017. Lagacy is VP of global information services and CIO at $CAT, and Livingston is president and CEO of $DOV.

$MSI {{ '2017-07-17T14:25:37+0000' | timeago}} • Announcement

$MSI said it will partner with AI company Neurala to develop intelligent cameras for public safety users. The cameras will help the police conduct search operations more efficiently. Initially, Neurala will work with Motorola to build a prototype that allows for real-time learning for a 'person of interest' search.

$KAMN {{ '2017-07-17T14:22:49+0000' | timeago}} • Announcement

Kaman Distribution Group, the distribution segment of $KAMN, named Jeff Ames as VP, GM of its Automation platform, effective July 10, 2017. Prior to joining Kaman, Jeff served as GM at $ETN.

Recent Transcripts

PHG (Koninklijke Philips N.V)
Monday, July 24 2017 - 8:00am
DOV (Dover Corporation)
Thursday, July 20 2017 - 2:00pm
PII (Polaris Industries Inc.)
Thursday, July 20 2017 - 2:00pm
ABT (Abbott Laboratories)
Thursday, July 20 2017 - 1:00pm
MDT (Medtronic plc)
Thursday, May 25 2017 - 12:00pm
ACAD (ACADIA Pharmaceuticals Inc.)
Tuesday, May 9 2017 - 9:00pm
STE (Steris Plc)
Tuesday, May 9 2017 - 2:00pm
ENDP (Endo International plc)
Tuesday, May 9 2017 - 12:30pm
IVC (Invacare Corporation)
Tuesday, May 9 2017 - 12:30pm
VRX (Valeant Pharmaceuticals International, Inc.)
Tuesday, May 9 2017 - 12:00pm
SNN (Smith & Nephew plc)
Friday, May 5 2017 - 7:30pm
MSI (Motorola Solutions, Inc.)
Thursday, May 4 2017 - 9:00pm
SPXC (SPX Corporation)
Thursday, May 4 2017 - 8:45pm
BMRN (BioMarin Pharmaceutical Inc.)
Thursday, May 4 2017 - 8:30pm
INCY (Incyte Corporation)
Thursday, May 4 2017 - 2:00pm
KAMN (Kaman Corporation)
Thursday, May 4 2017 - 12:30pm
WMGI (Wright Medical Group N.V.)
Wednesday, May 3 2017 - 8:30pm
MTRN (Materion Corporation)
Friday, April 28 2017 - 1:00pm
ROP (Roper Technologies, Inc.)
Friday, April 28 2017 - 12:30pm
JCI (Johnson Controls Inc.)
Thursday, April 27 2017 - 3:00pm

AlphaGraphics you may like